## Abstract Bone sialoprotein (BSP), an early marker of osteoblast differentiation. Whereas physical forces may play an important role in the regulation of bone cell function, little is known about how cells are able to sense mechanical loads. Chlorpromazine, a tranquilizing agent for treatments of
Regulation of bone sialoprotein (BSP) gene transcription by lipopolysaccharide
✍ Scribed by Naoko Kato; Youhei Nakayama; Yu Nakajima; Hiroshi Samoto; Ryoichiro Saito; Fumihiko Yamanouchi; Hiroshi Masunaga; Emi Shimizu; Yorimasa Ogata
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 275 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Lipopolysaccharide (LPS) is a major mediator of inflammatory responses in periodontal disease that inhibits bone formation and stimulates bone resorption. To determine the molecular mechanisms involved in the suppression of bone formation, we have analyzed the effects of LPS on BSP gene expression. Bone sialoprotein (BSP) is a mineralized tissue‐specific protein that appears to function in the initial mineralization of bone. Treatment of osteoblast‐like ROS 17/2.8 cells with LPS (1 µg/ml) for 12 h caused a marked reduction in BSP mRNA levels. The addition of antioxidant N‐acetylcysteine (NAC; 20 mM) 30 min prior to stimulation with LPS attenuated the inhibition of BSP mRNA levels. Transient transfection analyses, using chimeric constructs of the rat BSP gene promoter linked to a luciferase reporter gene, revealed that LPS (1 µg/ml) suppressed expression of luciferase construct, encompassing BSP promoter nucleotides −108 to +60, transfected into ROS17/2.8 cells. The effects of LPS were inhibited by protein kinase A (PKA) inhibitor, H89 and the tyrosine kinase inhibitor, herbimycin A (HA). Introduction of 2 bp mutations in the inverted CCAAT box (ATTGG; nts −50 and −46), a cAMP response element (CRE; nts −75 to −68), a FGF response element (FRE; nts −92 to −85), and a pituitary specific transcription factor binding element (Pit‐1; nts −111 to −105) showed that the LPS effects were mediated by the CRE and FRE. Whereas the FRE and 3′‐FRE DNA‐protein complexes were decreased by LPS, CRE DNA‐protein complex did not change after LPS treatment. These studies, therefore, show that LPS suppresses BSP gene transcription through PKA and tyrosine kinase‐dependent pathways and that the LPS effects are mediated through CRE and FRE elements in the proximal BSP gene promoter. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Transforming growth factor-b (TGF-b) increases steady-state mRNA levels of several extracellular matrix proteins in mineralized connective tissues. Bone sialoprotein (BSP) is a major constituent of the bone matrix, thought to initiate and regulate the formation of mineral crystals. To determine the
## Abstract This study identifies a __cis__‐acting element that confers tissue‐restricted expression to the bone sialoprotein (__BSP__) gene. Using both gain of function and loss‐of function studies, we demonstrate that this element acts as a tissue specific enhancer of BSP expression in osteoblast
## Abstract Bone sialoprotein (BSP) is an early marker of osteoblast differentiation. Androgens are steroid hormones that are essential for skeletal development. The androgen receptor (AR) is a transcription factor and a member of the steroid receptor superfamily that plays an important role in mal
## Abstract Parathyroid hormone (PTH) regulates serum calcium and inorganic phosphate levels through its actions on kidney and bone. Bone sialoprotein (BSP) is an early marker of osteoblast differentiation and bone metabolism. We here report that two cAMP response elements (CRE) in the human BSP ge
Bone sialoprotein (BSP) is an extracellular matrix protein that has a highly restricted expression to mineralized skeletal tissues. The chicken bone sialoprotein-encoding gene (bsp) was isolated and shown to contain two less exons than similar mammalian genes, with the absence of an untranslated 58